A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Efruxifermin in Non-Cirrhotic Subjects with Nonalcoholic Steatohepatitis (NASH)

Closed for enrollment

(956) 362-8047

Please contact us for more information or to learn if you are eligible to participate.

To evaluate the effect of EFX compared to placebo on fibrosis regression in NASH subjects with stage 2 or 3 fibrosis.

5323 S. McColl Rd., Edinburg, TX 78539

(956) 362-2390